1. Home
  2. PZZA vs CERT Comparison

PZZA vs CERT Comparison

Compare PZZA & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

HOLD

Current Price

$41.51

Market Cap

1.3B

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$8.76

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZZA
CERT
Founded
1984
2008
Country
United States
United States
Employees
N/A
1546
Industry
Restaurants
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1993
2020

Fundamental Metrics

Financial Performance
Metric
PZZA
CERT
Price
$41.51
$8.76
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$49.44
$13.88
AVG Volume (30 Days)
765.6K
2.0M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
4.44%
N/A
EPS Growth
N/A
N/A
EPS
1.14
0.07
Revenue
$2,086,399,000.00
$415,551,000.00
Revenue This Year
$2.60
$10.82
Revenue Next Year
N/A
$6.77
P/E Ratio
$36.38
$126.84
Revenue Growth
N/A
11.47
52 Week Low
$30.16
$8.03
52 Week High
$55.74
$15.69

Technical Indicators

Market Signals
Indicator
PZZA
CERT
Relative Strength Index (RSI) 45.44 40.96
Support Level $40.53 $8.95
Resistance Level $42.77 $9.42
Average True Range (ATR) 1.23 0.39
MACD 0.28 0.07
Stochastic Oscillator 29.67 25.99

Price Performance

Historical Comparison
PZZA
CERT

About PZZA Papa John's International Inc.

Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: